Omrix Biopharmaceuticals, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Entered a material agreement · Director / officer change · Other material eventNov 25, 2008
- Entered a material agreementNov 21, 2008
- Results of operationsNov 6, 2008
- Regulation FD disclosureOct 9, 2008
- Entered a material agreementSep 30, 2008
- Results of operationsAug 11, 2008
- Director / officer changeAug 11, 2008
- Other material eventMay 16, 2008
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AOMRIX BIOPHARMACEUTICALS, INC.Feb 17, 2009
- SC 13G/AOMRIX BIOPHARMACEUTICALS, INC.Feb 13, 2009
- 25-NSEDec 30, 2008
- 15F-12GFORM 15-12GDec 30, 2008
- SC 13D/ADec 30, 2008
- SC TO-T/AAMENDMENT NO. 6Dec 29, 2008
- SC TO-T/AAMENDMENT NO. 5Dec 19, 2008
- SC 14D9/ASCHEDULE 14D-9, AMENDMENT NO. 6Dec 19, 2008
- SC 14D9/AFORM SC 14D9ADec 19, 2008
- SC 13DDec 18, 2008
- SC TO-T/AAMENDMENT NO. 4Dec 17, 2008
- SC 14D9/ASCHEDULE 14D-9/ADec 17, 2008
- SC TO-T/AAMENDMENT NO. 3Dec 17, 2008
- CORRESPDec 16, 2008
- UPLOADDec 15, 2008